Affinity Biosensors
Affinity Biosensors is dedicated to providing the fastest and most accurate diagnostic solutions for antimicrobial susceptibility testing (AST). Their flagship product, the LifeScale AST system, utilizes innovative population profiling and AI technology to deliver rapid, reliable results, supporting better patient outcomes and antibiotic stewardship. The company aims to transform antibiotic susceptibility testing through advanced mass measurement and microfluidic sensor technology.
Industries
Nr. of Employees
small (1-50)
Affinity Biosensors
Santa Barbara, California, United States, North America
Products
Rapid benchtop AST system
A benchtop diagnostic platform that uses microfluidic single-cell mass sensing and machine learning to produce rapid phenotypic AST results from positive blood cultures in ~4.5 hours; compatible with standard well-plates and antibiotic panels.
Rapid benchtop AST system
A benchtop diagnostic platform that uses microfluidic single-cell mass sensing and machine learning to produce rapid phenotypic AST results from positive blood cultures in ~4.5 hours; compatible with standard well-plates and antibiotic panels.
Services
On-site laboratory evaluation and product trial
Provision of laboratory demonstrations and evaluation units to test platform performance in clinical laboratory settings.
Service and technical support
Post-sale service and support for instrument operation and troubleshooting.
On-site laboratory evaluation and product trial
Provision of laboratory demonstrations and evaluation units to test platform performance in clinical laboratory settings.
Service and technical support
Post-sale service and support for instrument operation and troubleshooting.
Expertise Areas
- Rapid phenotypic antimicrobial susceptibility testing
- Microfluidic single-cell measurement
- AI-driven MIC prediction
- Clinical microbiology validation
Key Technologies
- Microfluidics
- Single-cell mass sensing
- Population profiling
- Machine learning/AI for diagnostics